Abnormal Uterine Bleeding

Chapter

Abstract

Abnormal uterine bleeding (AUB) accounts for a third of office visits to a gynecologist. It also accounts for majority of gynecological consults in perimenopausal and postmenopausal women. The International Federation of Gynecology and Obstetrics (FIGO) proposed a classification system with standardized terminology for the causes of AUB. Obtaining a thorough history and physical examination at the initial office visit is important to plan a treatment scheme. Although treatment is individualized, medical therapy is commonly the first-line management especially in young women. For hemodynamically stable patients, common medical treatment options include combination or progestin-only hormonal therapy, gonadotropin-releasing hormone, or tranexamic acid. Patients with contraindications to medical therapy or failed to respond to medical treatment would require surgical options. Similar to medical therapy, surgical management relies on diagnosis, underlying pathology, and patient’s interest in maintaining fertility.

Keywords

Abnormal uterine bleeding Heavy menstrual bleeding International Federation of Gynecology and Obstetrics PALM-COEIN Endometrial polyp Leiomyoma 

References

  1. 1.
    American College of Obstetricians and Gynecologists. Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice bulletin no. 128. Obstet Gynecol. 2012;120:197–206.Google Scholar
  2. 2.
    Fraser IS, Critchley HO, Munro MG, Broder M. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Writing Group for this Menstrual Agreement Process [published erratum appears in Fertil Steril 2007;88:538]. Fertil Steril. 2007;87:466–76.CrossRefGoogle Scholar
  3. 3.
    Data fromMunro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gyn Obstet. 2011;113:3–13.CrossRefGoogle Scholar
  4. 4.
    American College of Obstetricians and Gynecologists. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. ACOG Committee opinion no. 349. Obstet Gynecol. 2006;108:1323–8.Google Scholar
  5. 5.
    James AH, Kouides PA, Abdul-Kadir R, Dietrich JE, Edlund M, Federici AB, et al. Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol Reprod Biol. 2011;158:124–34.CrossRefGoogle Scholar
  6. 6.
    National Heart, Lung, and Blood Institute. The diagnosis, evaluation, and management of von Willebrand disease, NIH Publication No. 08-5832. Bethesda: NHLBI; 2007. Available at http://www.nhlbi.nih.gov/guidelines/vwd/vwd.pdf. Retrieved 5 Dec 2012.Google Scholar
  7. 7.
    Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288:1610–21. (Meta-analysis).CrossRefGoogle Scholar
  8. 8.
    Black A, Francoeur D, Rowe T, et al. Society of Obstetrics and Gynaecology of Canada. Canadian contraception consensus. J Obstet Gynaecol Can. 2004;26:347–87, 389–436.Google Scholar
  9. 9.
    National heart, Lung, and Blood Institute. The diagnosis, evaluation, and management of von Willebrand disease. NIH Pub. No. 08-5832; 2007. Available at: http://www.nhlbi.nih.gov/files/docs/guidelines/vwd.pdf. Retrieved 15 Feb 2016.
  10. 10.
    Bradley LD, Gueye N-A. The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol. 2016;214:31–44.CrossRefGoogle Scholar
  11. 11.
    DeVore GR, Owens O, Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding—a double-blind randomized control study. Obstet Gynecol. 1982;59:285–91.PubMedGoogle Scholar
  12. 12.
    Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol. 2006;108:924–9.CrossRefGoogle Scholar
  13. 13.
    American College of Obstetricians and Gynecologists. ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013;121:891–6.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyPresence Saint Francis HospitalEvanstonUSA

Personalised recommendations